Oncostellae is a clinical-stage biopharmaceutical company pioneering the discovery and development of proprietary drug candidates that address high unmet medical needs in immunology and oncology.

Founded in 2013 by a team of medicinal chemists and pharmacologists with a collective track record in drug discovery, the company brings together the experience and network of collaborators to develop clinical candidates from conception through to Phase I/II. Further development and commercialization rights are licensed to consolidated pharmaceutical companies.